Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Vogler

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Applied Health Economics and Health Policy|May 5, 2022
Centralised Pharmaceutical Procurement: Learnings from Six European CountriesSabine Vogler, Eveli Bauer, Katharina Habimana
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|December 29, 2023
<b>How to Price and to Reimburse Publicly Funded Medicines in Latin America?</b> Lessons Learned from EuropeChristine Leopold, Sergio Poblete, Sabine Vogler
Health Policy OPEN|October 21, 2024
Improving antibiotic prescribing - Recommendations for funding and pricing policies to enhance use of point-of-care testsSabine Vogler, Caroline Steigenberger, Friederike Windisch
Expert Review of Pharmacoeconomics & Outcomes Research|November 24, 2018
Review of studies reporting actual prices for medicinesNika Mardetko, Mitja Kos, Sabine Vogler
Cost Effectiveness and Resource Allocation : C/E|December 9, 2020
Impact of changes in the methodology of external price referencing on medicine prices: discrete-event simulationSabine Vogler, Peter Schneider, Lena Lepuschütz
Health Policy (Amsterdam, Netherlands)|June 26, 2014
Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countriesSabine Vogler, Katharina Habimana, Danielle Arts
Diagnostics (Basel, Switzerland)|December 9, 2023
Barriers and Facilitators in Pricing and Funding Policies of European Countries That Impact the Use of Point-of-Care Diagnostics for Acute Respiratory Tract Infections in Outpatient PracticesCaroline Steigenberger, Friederike Windisch, Sabine Vogler
Pharmacoeconomics - Open|February 6, 2019
Evolution of Average European Medicine Prices: Implications for the Methodology of External Price ReferencingSabine Vogler, Peter Schneider, Nina Zimmermann
Applied Health Economics and Health Policy|September 12, 2019
Financial Burden of Prescribed Medicines Included in Outpatient Benefits Package Schemes: Comparative Analysis of Co-Payments for Reimbursable Medicines in European CountriesSabine Vogler, Guillaume Dedet, Hanne Bak Pedersen
Research in Social & Administrative Pharmacy : RSAP|March 12, 2025
Community pharmacy services in the late COVID-19 period: What has driven change?Sabine Vogler, Verena Knoll, Maximilian Salcher-Konrad
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Applied Health Economics and Health Policy|May 5, 2022
Centralised Pharmaceutical Procurement: Learnings from Six European CountriesSabine Vogler, Eveli Bauer, Katharina Habimana
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|December 29, 2023
<b>How to Price and to Reimburse Publicly Funded Medicines in Latin America?</b> Lessons Learned from EuropeChristine Leopold, Sergio Poblete, Sabine Vogler
Health Policy OPEN|October 21, 2024
Improving antibiotic prescribing - Recommendations for funding and pricing policies to enhance use of point-of-care testsSabine Vogler, Caroline Steigenberger, Friederike Windisch
Expert Review of Pharmacoeconomics & Outcomes Research|November 24, 2018
Review of studies reporting actual prices for medicinesNika Mardetko, Mitja Kos, Sabine Vogler
Cost Effectiveness and Resource Allocation : C/E|December 9, 2020
Impact of changes in the methodology of external price referencing on medicine prices: discrete-event simulationSabine Vogler, Peter Schneider, Lena Lepuschütz
Health Policy (Amsterdam, Netherlands)|June 26, 2014
Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countriesSabine Vogler, Katharina Habimana, Danielle Arts
Diagnostics (Basel, Switzerland)|December 9, 2023
Barriers and Facilitators in Pricing and Funding Policies of European Countries That Impact the Use of Point-of-Care Diagnostics for Acute Respiratory Tract Infections in Outpatient PracticesCaroline Steigenberger, Friederike Windisch, Sabine Vogler
Pharmacoeconomics - Open|February 6, 2019
Evolution of Average European Medicine Prices: Implications for the Methodology of External Price ReferencingSabine Vogler, Peter Schneider, Nina Zimmermann
Applied Health Economics and Health Policy|September 12, 2019
Financial Burden of Prescribed Medicines Included in Outpatient Benefits Package Schemes: Comparative Analysis of Co-Payments for Reimbursable Medicines in European CountriesSabine Vogler, Guillaume Dedet, Hanne Bak Pedersen
Research in Social & Administrative Pharmacy : RSAP|March 12, 2025
Community pharmacy services in the late COVID-19 period: What has driven change?Sabine Vogler, Verena Knoll, Maximilian Salcher-Konrad
Pageof 6